CN117916361A - 天然杀伤(nk)细胞的细胞培养基 - Google Patents
天然杀伤(nk)细胞的细胞培养基 Download PDFInfo
- Publication number
- CN117916361A CN117916361A CN202280061271.0A CN202280061271A CN117916361A CN 117916361 A CN117916361 A CN 117916361A CN 202280061271 A CN202280061271 A CN 202280061271A CN 117916361 A CN117916361 A CN 117916361A
- Authority
- CN
- China
- Prior art keywords
- concentration
- cells
- acid
- medium
- plant extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0646—Natural killers cells [NK], NKT cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/7051—T-cell receptor (TcR)-CD3 complex
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/24—Iron; Fe chelators; Transferrin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/44—Thiols, e.g. mercaptoethanol
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/70—Undefined extracts
- C12N2500/76—Undefined extracts from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/105—Insulin-like growth factors [IGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/33—Insulin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/50—Cell markers; Cell surface determinants
- C12N2501/599—Cell markers; Cell surface determinants with CD designations not provided for elsewhere
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163230189P | 2021-08-06 | 2021-08-06 | |
| US63/230,189 | 2021-08-06 | ||
| PCT/US2022/039376 WO2023014855A1 (en) | 2021-08-06 | 2022-08-04 | Cell culture medium for natural killer (nk) cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN117916361A true CN117916361A (zh) | 2024-04-19 |
Family
ID=83507455
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202280061271.0A Pending CN117916361A (zh) | 2021-08-06 | 2022-08-04 | 天然杀伤(nk)细胞的细胞培养基 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240360412A1 (https=) |
| EP (1) | EP4381049A1 (https=) |
| JP (1) | JP2024529565A (https=) |
| KR (1) | KR20240041979A (https=) |
| CN (1) | CN117916361A (https=) |
| CA (1) | CA3227822A1 (https=) |
| WO (1) | WO2023014855A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20240177181A (ko) * | 2023-06-19 | 2024-12-27 | (주)엑셀세라퓨틱스 | Nk 세포 배양용 배지 조성물 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111500535B (zh) * | 2020-04-30 | 2023-04-14 | 惠和生物技术(上海)有限公司 | 用于体外培养人自然杀伤细胞的方法和培养基 |
-
2022
- 2022-08-04 CA CA3227822A patent/CA3227822A1/en active Pending
- 2022-08-04 CN CN202280061271.0A patent/CN117916361A/zh active Pending
- 2022-08-04 JP JP2024532364A patent/JP2024529565A/ja active Pending
- 2022-08-04 KR KR1020247006606A patent/KR20240041979A/ko active Pending
- 2022-08-04 US US18/294,221 patent/US20240360412A1/en active Pending
- 2022-08-04 EP EP22782779.7A patent/EP4381049A1/en active Pending
- 2022-08-04 WO PCT/US2022/039376 patent/WO2023014855A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| JP2024529565A (ja) | 2024-08-06 |
| KR20240041979A (ko) | 2024-04-01 |
| WO2023014855A1 (en) | 2023-02-09 |
| CA3227822A1 (en) | 2023-02-09 |
| US20240360412A1 (en) | 2024-10-31 |
| EP4381049A1 (en) | 2024-06-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12517112B2 (en) | Immune cell organoid co-cultures | |
| CN106834212B (zh) | 一种用于肺组织3d培养的培养基 | |
| Chang et al. | Isolation of mesenchymal stem cells with neurogenic potential from the mesoderm of the amniotic membrane | |
| CN1309180A (zh) | 用于来自脂肪组织的基质细胞的多中胚层谱系分化潜能和其用途 | |
| CN115558641B (zh) | 高纯度效应免疫细胞群及其培养方法、试剂组合物和应用 | |
| JP2024501020A (ja) | 操作されたガンマデルタt細胞ならびにその作製方法および使用方法 | |
| CN107475192B (zh) | 一种以记忆干t细胞为主要成分的淋巴细胞群及其体外高效扩增方法 | |
| CN115651903B (zh) | 高杀伤力的免疫细胞群及其培养方法、试剂组合物和应用 | |
| WO2020027094A1 (ja) | iPS細胞を介して再生T細胞集団を製造する方法 | |
| CN117916361A (zh) | 天然杀伤(nk)细胞的细胞培养基 | |
| Lei et al. | Calreticulin as a special marker to distinguish dental pulp stem cells from gingival mesenchymal stem cells | |
| HK40103422A (zh) | 天然杀伤(nk)细胞的细胞培养基 | |
| CN119286780B (zh) | 一种t细胞的体外培养方法 | |
| CN112481207B (zh) | 一种脂肪干细胞在促进脐带血造血干细胞增殖的方法 | |
| CN1667119A (zh) | 一种成体干细胞及其培养方法和用途 | |
| CN112080469A (zh) | T1肽在体外促进脐带血造血干细胞增殖中的应用 | |
| WO2024220222A1 (en) | Media and methods for differentiating t cells from hematopoietic stem cells | |
| CN113461797B (zh) | 一种输卵管癌靶标抗原、输卵管癌靶标抗原刺激培养的ctl细胞及其应用 | |
| CA2408756A1 (en) | Immune potentiating compositions | |
| US20220233665A1 (en) | Medicinal composition | |
| EP4130253A1 (en) | T cell progenitor production method | |
| Cantrell et al. | Signaling pathways induced by a tumor-derived vaccine in antigen presenting cells | |
| KR102414138B1 (ko) | Wnt 단백질 활성 증진용 배지 조성물 | |
| KR102038503B1 (ko) | 고기능성 간세포의 분화방법 | |
| Chou | Identification of bioactive yeastolate fractions responsible for insect cell growth and baculovirus production |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| CB03 | Change of inventor or designer information |
Inventor after: R Ao Heli Inventor after: D. Santag Inventor after: J. Kahun Inventor after: Gilles Lambert Inventor before: R Ao Heli Inventor before: S. Santag Inventor before: J. Kahun Inventor before: Gilles Lambert |
|
| CB03 | Change of inventor or designer information | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40103422 Country of ref document: HK |
|
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |